WASHINGTON, D.C. — The White House announced that it is adding three drugs for diabetes and lung disease to the self-pay platform TrumpRx. The three drugs are from German drugmaker Boehringer Ingelheim.

The drugs are Jentadueto and Jentadueto XR for Type 2 diabetes and Striverdi Respimat for chronic obstructive pulmonary disease. Jentadueto and Jentadueto XR have a list price of about $525 but are priced on TrumpRx starting around $55. Striverdi Respimat has a list price of about $276 but is listed on TrumpRx at about $35.

Boehringer Ingelheim is the ninth drugmaker to join the TrumpRx platform. The site has fewer than 60 drugs listed. TrumpRx platform launched in January as part of President Donald Trump's broader push to address rising health care costs.

Discount prices listed on GoodRx tend to be higher than the prices on TrumpRx for the added drugs. The site primarily offers discounts on brand-name drugs that have cheaper generic equivalents. Similar prices can also be found on other discount sites.

Jentadueto has a generic version that is typically cheaper. Patients typically pay about $25 to $35 at the pharmacy counter for the generic version of Jentadueto.

Ben Link, a contributor at 46brooklyn, said "Those are pretty significant discounts." Discounts on the site cannot be used with insurance or applied toward deductibles.

Chris Klomp, a senior Department of Health and Human Services official, said "The goal was not actually some massive reach." Chris Klomp said that TrumpRx was never meant to be used by people with health insurance. Chris Klomp said that the site is a limited, cash-pay tool rather than a systemwide fix for drug prices.

A survey published by KFF found that about one in three people who take prescription drugs had heard at least something about TrumpRx. Of those who had heard about TrumpRx, 7% said they had visited the site to compare prices. Among people who take GLP-1 medications, about 16% said they had visited the site to compare prices.

The White House declined to say how many people have visited the site since it launched. A poll published by West Health-Gallup found that about one in three U.S. adults said they had made trade-offs to afford health care in the past year, including rationing or skipping medications.